Tuesday, March 28, 2023
Two-Time Lasker Awardee and Internationally Acclaimed Virologist, Robert C. Gallo, MD, To Step Down as Director of UM School of Medicine’s Institute of Human Virology (IHV)
Robert C. Gallo, MD, one of the world’s leading virologists and cancer researchers, announced he has stepped down from his position as Director of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM), effective March 24.
Thursday, March 09, 2023
Leading Physician-Scientist Dr. William F. Regine Named Senior Associate Dean for Clinical Affairs at UM School of Medicine and President of UM Faculty Physicians, Inc.
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD announced today that William F. Regine, MD, FACR, FASTRO, FACRO has been appointed to the executive role of Senior Associate Dean for Clinical Affairs at the University of Maryland School of Medicine (SOM), effective immediately.
.jpg)
Wednesday, March 01, 2023
Internationally-Renowned Scientist Claire Fraser, PhD, To Step Down as Director of the University of Maryland School of Medicine's Institute for Genome Sciences
Claire Fraser, PhD, a pioneer and global leader in genomic research, has announced that she will step down from her position as Director of the Institute for Genome Sciences (IGS) in the University of Maryland School of Medicine (UMSOM). She will now continue as the Dean E. Albert Reece Endowed Professor and Professor of Medicine and Microbiology and Immunology at UMSOM and scientist at IGS until she retires in 2024.
Thursday, February 23, 2023
Baltimore PKD Research and Clinical Core Center Receives Prestigious ‘Center of Excellence’ Designation from PKD Foundation
The PKD Foundation recently recognized the University of Maryland School of Medicine’s (UMSOM) clinical center that treats polycystic kidney disease (PKD)with a highly prestigious “Center of Excellence” designation. The designation recognizes the center as a leader in providing multidisciplinary, comprehensive clinical services for families affected by autosomal dominant polycystic kidney disease (ADPKD), a hereditary condition. It is one of just 28 clinical centers in the U.S.to receive this recognition.
Wednesday, February 22, 2023
Parkinson’s Disease Patients Experience Significant Reduction in Symptoms with Non-Surgical Focused Ultrasound Treatment
Patients with Parkinson’s disease achieved a significant improvement in their tremors, mobility, and other physical symptoms after having a minimally invasive procedure involving focused ultrasound, according to a new study today published in the New England Journal of Medicine.
Wednesday, February 22, 2023
The Molecular Mechanism Behind Abdominal Aneurysms
When the artery that supplies the stomach and the liver forms a bulge that ruptures, this medical emergency results in the deaths of 50 percent of patients before they reach the hospital. This “silent killer” condition, known as abdominal aortic aneurysm , led to the death of Albert Einstein — and is responsible for nearly 5,000 deaths in the U.S. each year. Now researchers have found new clues that eventually could lead to earlier detection methods to save lives in the future.
Wednesday, February 22, 2023
University of Maryland School of Medicine Professor Appointed Chief of New Branch at NIH
Ronna Hertzano, MD, PhD, Professor of Otorhinolaryngology-Head & Neck Surgery, at the University of Maryland School of Medicine (UMSOM) has been appointed as Chief of the newly established Neurotology Branch in The National Institute on Deafness and Other Communication Disorders (NIDCD).
Friday, February 17, 2023
Neuroscience Tool’s Structure May Lead to Next Gen Versions
In order to more fully understand how diseases arise in the brain, scientists must unravel the intricate way neurons relay messages (either chemical or electrical) along a complex web of nerve cells. One way is by using a tool called DREADDs, which stands for Designer Receptors Activated by Designer Drugs. When introduced to a nerve cell or neuron, DREADDs acts like a specialized lock that only works when a key — in the form of a synthetic designer drug — fits into that lock. DREADDs can enable researchers to turn specific cell functions on or off to examine groups of neurons in circuits more precisely.
Wednesday, February 01, 2023
IN MEMORIAM: Mark J. Cowan, MD
The School of Medicine Community mourns the loss of one of our faculty members, Mark J. Cowan, MD, who passed away yesterday following a brief illness. Dr. Cowan was an outstanding pulmonologist and Associate Professor in the Department of Medicine. He is survived by his wife, Lauren Strong Cowan.
Tuesday, January 31, 2023
Artificial Blood Product One Step Closer to Reality With $46 Million in Federal Funding
A University of Maryland School of Medicine (UMSOM) physician-scientist will head a new federally-funded research program to develop and test a whole blood product, storable at room temperature, that can be used to transfuse wounded soldiers in the field within 30 minutes of injury, potentially saving thousands of lives. UMSOM will manage the $46.4 million four-year research project administered by the Defense Advanced Research Projects Agency (DARPA) in collaboration the University of Maryland School of Pharmacy (UMSOP) and more than a dozen universities and biotech companies.